SPEAKERS & TOPICS
Director of Prostate MR Imaging and Interventions and UCLA Prostate MR Imaging Research Group
Topic: PROSTATE CANCER IMAGING in 2024
Biography: Dr. Raman is an expert in Abdominal and Pelvic imaging (CT, MRI, Ultrasound and X-Ray) and interventional radiology (image guided procedures), especially in the area of tumor ablation and Fibroid Treatment. He is also director of the Abdominal Imaging Fellowship at UCLA, and co-director of the Fibroid Treatment Program at UCLA.
Learn more about Dr. Raman here: https://www.uclahealth.org/providers/steven-raman
MEDICAL DIRECTOR, PROSTATE ONCOLOGY SPECIALISTS, INC., Marina del Rey, CA & EXECUTIVE DIRECTOR, PROSTATE CANCER RESEARCH INSTITUTE, Culver City, CA
TOPIC: SPEAKER & HOST
A double board-certified medical oncologist, Mark C. Scholz, MD, serves as executive director of the Prostate Cancer Research Institute (PCRI) and medical director of Prostate Oncology Specialists Inc. in Marina del Rey, CA, a medical practice exclusively focused on prostate cancer. He received his medical degree from Creighton University in Omaha, NE. Dr. Scholz completed his Internal Medicine internship and Medical Oncology fellowship at University of Southern California Medical Center.
Dr. Scholz is a strong advocate for patient empowerment. He is the co-author of the book Invasion of the Prostate Snatchers: No More Unnecessary Biopsies, Radical Treatment or Loss of Potency and the author of The Key to Prostate Cancer: 30 Experts Explain 15 Stages of Prostate Cancer. He has written and produced extensive educational material on the subject of prostate cancer in various media including DVDs, blogs, newsletters and pamphlets. He is an invited guest speaker at prostate cancer conferences and support groups throughout the world. He is also an educational speaker on behalf of Amgen, Dendreon and Sanofi-Aventis.
Dr. Scholz is at and co-founder of the Prostate Cancer Research Institute (PCRI), a non-profit organization dedicated to patient education and research. PCRI clinical research on the topic of hormone therapy has been published in the Journal of Urology, The Prostate, and UROLOGY. The PCRI also provides financial support for research endeavors in the area of active surveillance, prostate imaging, and the development of new tumor markers. Future directions for PCRI research are aimed at enhancing the anticancer function of the immune system, developing treatments to prevent bone metastases, and evaluating the impact of nutritional supplements.
Dr. Scholz served as oncology director at the Memorial Campus of the Centinela Freeman Regional Medical Center from 1996-2001. His current hospital affiliations include St. John’s Health Center, Marina del Rey Hospital. His society memberships include the American Society of Clinical Oncology, American Society of Therapeutic Radiology, American Urologic Associate and European Associate of Urology. He continues as a primary investigator actively supervising a number of ongoing prostate cancer clinical trials and has authored or coauthored over 90 scholarly articles and abstracts in his area of expertise.
Learn more about Dr. Scholz here: https://pcri.org/mark-scholz
Chief of the Division of Urology and the Ronald L. Chez Family and Richard Melman Family Endowed Chair at NorthShore University Health System
Topic: Genetic & Germline Testing In Prostate Cancer
Biography: Brian T. Helfand, MD, PhD, is Chief of the Division of Urology and the Ronald L. Chez Family and Richard Melman Family Endowed Chair at NorthShore University HealthSystem. He is Director of the Personalized Prostate Program and Director of Clinical Research in the Program for Personalized Cancer Care (PPCC). He is also an active surgical scientist who is involved in the care of patients with prostate cancer. His clinical care and research is focused on the implementation of genetic tests and biomarker studies for prostate cancer. Dr. Helfand completed his undergraduate degree at Emory University. He received his medical training and PhD in Cell and Molecular Biology and Genetics from Northwestern University. He is a fellowship-trained urologic oncologist who has focused his research career on prostate cancer. He was recruited in 2011 from Northwestern University’s Feinberg School of Medicine, where he was faculty in the Department of Urology. Dr. Helfand is an internationally-known urologist and genomic translational researcher. He has received multiple grants from the NIH and has published over 140 peer-reviewed manuscripts. His best friend in 2024 is Mark A. Moyad, MD, MPH.
Learn more about Dr. Helfand here: https://www.northshore.org/apps/findadoctor/physicians/brian-t.-helfand
Professor of Urology and Immunology at the Mayo Clinic in Rochester, Minnesota
Topic: Fact or Fiction: an In-Depth Q&A Session on Advanced Treatments & Side Effects with Dr. Kwon & Dr. Moyad
Biography: Dr. Eugene D. Kwon is a full Professor of Urology and Immunology at the Mayo Clinic in Rochester, Minnesota. In addition, Dr. Kwon is the Director of Cancer Immunology and lmmunotherapy for the Mayo Comprehensive Cancer Center. Dr. Kwon also serves as the Vice-chair for the Mayo Clinic Institutional Review Board. Dr. Kwon received his undergraduate degree in Chemistry from Grinnell College and his M.D. degree from Rush Medical College in Chicago, Illinois. Dr. Kwon completed his urology resident training at the University of Iowa Hospitals and Clinics, while also completing an American Cancer Society sponsored fellowship in oncology. From 1992 until 1998, Dr. Kwon served as a National Research Service Award Postdoctoral Fellow within the Laboratory of Kidney Electrolyte and Metabolism at the National Heart, Lung and Blood Institutes at the NIH. During that time frame, Dr. Kwon also served as one of twelve research officers for the Special Research Officers Group of the Public Health Service.
Learn more about Dr. Kwon here: https://www.mayoclinic.org/biographies/kwon-eugene-d-m-d/bio-20054440
Jenkins/Pokempner Director of Complementary and Alternative Medicine (CAM) Education at the University of Michigan Medical Center in the Department of Urology
Topic: Moderator & Speaker
Mark A. Moyad, MD, MPH, Dr. Moyad’s mission is to promote a greater attention to comprehensive lifestyle changes to improve overall mental, physical, and spiritual wellness along with contributing to more objective education on dietary supplements, OTC, and other potential health options. This has been the focus of his research, writings, and lectures his entire career. He occupies an endowed position, which was originally created and funded by the individuals he has empowered over the past 25+ years.
He is the Jenkins/Pokempner Director of Complementary and Alternative Medicine (CAM) Education at the University of Michigan Medical Center in the Department of Urology. This was one of the first endowments of its kind created for a doctor at a major medical center. Dr. Moyad has always considered himself to be first, and foremost, a public health educator with an expertise in clinical/medical epidemiology. Mark received his medical education from the University of South Florida College of Public Health and the Wayne State University School of Medicine. He is the primary author of over 150 medical journal publications on lifestyle changes and supplements, the past editor-in-chief of the medical journal Seminars in Preventive & Alternative Medicine, past CAM course director for a variety of medical societies, continues to be a guest editor and provide peer review for multiple medical journals, and he has given 1000s of lectures around the world to the public and health care professionals in virtually every medical specialty and major medical center. Mark is the author or co-author of 15 academic and consumer books, including his most recent updated 5th edition Promoting Wellness coming out late summer 2022. He now interviews other health experts on a variety of global wellness topics to enhance notable health care professional and patient education sources. He has provided educational clinical research updates for the last 20+ years to health care professionals and national patient advocacy groups. He has been a consultant and/or interviewed for most major magazines, websites, radio, and television shows devoted to health in the U.S. and appears regularly on a variety of network news/programs. Dr. Moyad also loves running, resistance exercise in moderation, artichokes, his wife Mia and kids, any University of Michigan Athletic team when they are winning, and their dog “Grazie”, but of course not in that specific order.
PS. He is also the moderator (for PCRI) of the largest patient conference in the world but hopes to relinquish this position one day soon in order to pursue his real passion and calling in life-being a part-time ESPN Sportscaster and a full-time international male model while simultaneously being further lionized by millions of fans with and without a prostate by becoming a world renowned bodybuilding champion (aka the next "Mr Olympia").
Dr. Moyad serves as a public health and education expert to the public and health care professionals around the world. He does not see patients in clinic. For any questions regarding prostate cancer, you can contact the PCRI Helpline at: help@pcri.org
Learn more about Dr. Moyad here: https://pcri.org/mark-moyad